CONCLUSION:
We demonstrate that a single, large-volume transplant program was able
to grow volume with little difference in donor variables and clinical
outcomes following transplant. While multiple reasons are possible, most
likely the reduction of volume at other programs allowed us to utilize
organs to which we would not have previously had access. More
significantly, our growth in volume was coupled with no instances of
COVID-19 infection or transmission amongst patients or staff due to an
aggressive testing and surveillance program.